Skip to content

Welcome to the new Aloha Fungi shop!Have a question or an idea? Message us on WhatsApp: MattKubaFranek

Cordyceps: who should be careful and when to ask a doctor

Cordyceps contraindications: immunosuppressants, diabetes and blood-thinning medication, pregnancy, autoimmune disease. When to ask a doctor before you start.

Mateusz Rosa

TCM therapist · Doctor of Acupuncture (WFAS) · author of a book on functional mushrooms

5 min read

Cordyceps: who should be careful and when to ask a doctor
Contents

Cordyceps contraindications are a question to ask before the first capsule, not after. The short answer: cordyceps is not for everyone. If you take medication daily, are pregnant or breastfeeding, or have an active autoimmune condition, talk to a doctor or pharmacist first. The rest of this post says who this concerns and how to have that conversation.

I write this as someone who sells cordyceps. I could say "go ahead". I won't, because I have spent years in a clinic and I know the question "can I take this" usually comes too late, with the jar already in hand.

Is cordyceps for everyone?

No. Cordyceps is a concentrated mushroom extract, not a miracle tea. It contains β-glucans and nucleosides, molecules the body recognises and responds to. For most healthy adults it is an ordinary part of a morning ritual. For a few specific groups it is a topic for a specialist before they start.

The word "natural" changes nothing here. Coffee is natural too, and with some medication a doctor will tell you to drop it.

Who should ask a doctor before taking cordyceps?

Five groups ask a doctor or pharmacist before cordyceps: people on immunosuppressants, people with active autoimmune disease, people on diabetes or blood-thinning medication, and women who are pregnant or breastfeeding. Add anyone under 18. In each of these situations talking to a specialist is plain caution, not overkill. One by one:

  • Immunosuppressants, for example after a transplant. Cordyceps contains β-glucans that have been studied for their effect on immune cells. We describe this in how cordyceps works. If your medication deliberately dampens immunity, that alone is reason enough to ask.
  • Active autoimmune disease. Same reason as above: if your immune system is already dysregulated, do not add anything to it without a consultation.
  • Diabetes medication. Your doctor will check whether a new supplement means watching glucose more closely in the first weeks.
  • Blood-thinning medication. The rule is simple: every new extract gets reported to your treating doctor, just as with Lion's Mane or Reishi.
  • Pregnancy, breastfeeding, under 18. No studies in these groups means no data, and no data does not mean "safe". Our labels say so outright.

This is a list of the situations we see most often, not a complete inventory. Your medical history is longer than this post, and your doctor knows it, not me.

Why "natural" does not mean "neutral"?

A food supplement enters the body as really as anything else you swallow daily. Cordyceps sold in Poland is usually a 10:1 extract: ten kilograms of fruiting bodies in one kilogram of powder. That is no longer "a mushroom with dinner". It is concentrated, so it deserves the attention you give a new over-the-counter medicine.

How to talk to a doctor so the conversation is concrete?

A conversation with a doctor or pharmacist about cordyceps is useful when you bring specifics instead of "can I take mushrooms". Bring your medication list with doses, the supplement label showing species, mushroom part and serving, and one sentence about what you want to check. Concretely:

  1. A list of medication you take daily, with doses.
  2. The supplement label you are considering, or a photo of the ingredients. It should show the species (Cordyceps militaris), the part of the mushroom (fruiting body) and the daily serving.
  3. One sentence: "I want to check that this extract does not interact with my medication before I start".

A pharmacist will answer that in five minutes. Your treating doctor, if you have a chronic condition, at the next visit. Both routes are fine.

What if none of this applies to you?

Then there is no reason to worry. This post is not meant to put you off functional mushrooms; it is meant to make the decision yours and informed. If you are a healthy adult on no regular medication, the simplest start is the morning ritual: one form, one time of day, a week of observation.

Frequently asked questions

Can I take cordyceps with coffee? Yes, powder and drops dissolve well in a warm drink. The medication question is separate from the coffee question.

Can I take cordyceps every day? Tradition wove it into a daily routine rather than occasional use. If you belong to one of the groups above, discuss frequency with a specialist too.

Does cordyceps interact with medication? It can, which is why with immunosuppressants, diabetes and blood-thinning medication you ask a doctor or pharmacist first. Do not settle this yourself based on a text online, including this one.

Is cordyceps safe in pregnancy? There are no studies in this group, so there is no basis to say "yes". In pregnancy and while breastfeeding, discuss every new supplement with your doctor.


This content is for educational purposes only and does not constitute medical advice. A food supplement does not replace a varied diet or a healthy lifestyle. If in doubt, consult your doctor or pharmacist.

Cordyceps in scientific research

What was studied, on how many people and with what level of evidence. This overview describes studies, not the effects of a product.

9

human studies

3

placebo-controlled RCTs

20002026

years of publication

  • Zhou J. et al., 2021

    C

    RCT, double-blind, placebo-controlled

    59 people

    The study examined Cordyceps militaris as an add-on to duloxetine for insomnia associated with depression, in a group of 59 people, using a double-blind, placebo-controlled RCT design.

    PMID 34858228
  • Ontawong A. et al., 2024

    C

    RCT

    40 healthy adults

    The study examined the effect of a Cordyceps militaris beverage on immune response in 40 healthy adults, using an RCT design.

    PMID 38580687
  • Dubhashi S. et al., 2023

    C

    RCT, double-blind, placebo-controlled

    65 enrolled, 58 evaluated

    The study examined Cordyceps militaris in mild-to-moderate COVID-19, using a double-blind, placebo-controlled RCT, with 65 people enrolled (58 evaluated).

    PMID 37727187
  • Yang E.-J. et al., 2026

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The narrative review collected in vitro, in vivo and clinical data on Cordyceps militaris.

    PMID 41432716
  • Shu M.-Y. et al., 2025

    B

    systematic review with meta-analysis

    14 RCTs, 528 athletes

    The systematic review with meta-analysis collected 14 RCTs (528 athletes) on functional mushroom supplementation in athletes; the review covers multiple mushroom species at once, not only Cordyceps militaris.

    PMID 41280379
  • Choi E. et al., 2020

    E

    animal study (mice) · preclinical studies (in vitro and rodent)

    not applicable

    The mouse study examined the effect of Cordyceps militaris on physical performance.

    PMID 33312018
  • Hirsch K.R. et al., 2017

    C

    RCT, double-blind, placebo-controlled (mushroom blend, not an isolated species)

    28 (acute phase), 10 (chronic phase)

    The study examined the effect of a mushroom blend containing C. militaris (4 g/day) on VO2max, time to exhaustion, ventilatory threshold and power in a cycle ergometer test, using 1-week and 3-week protocols in trained adults. Limitations: n=10 in the chronic phase, a multi-ingredient preparation not isolating the species.

    PMID 27408987
  • Jędrejko M. et al., 2026

    E

    narrative review of human studies · preclinical studies (in vitro and rodent)

    5 studies, 321 participants aged 16-35

    The narrative review collected 5 intervention studies (2017-2024) on ergogenic effects and post-exercise recovery with supplementation in humans. Small samples, heterogeneous participants and protocols, incomplete randomisation reporting, most studies not registered.

    PMID 41829950
  • Tuli H.S. et al., 2014

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The review discussed the pharmacological potential of the genus Cordyceps, with particular focus on cordycepin, based on in vitro/in vivo data.

    DOI 10.1007/s13205-013-0121-9
  • Olatunji O.J. et al., 2018

    E

    narrative review (whole genus Cordyceps) · preclinical studies (in vitro and rodent)

    not applicable

    The review collected traditional uses, phytochemistry and pharmacology of the entire genus Cordyceps without separating species.

    PMID 29775778
  • Du J. et al., 2021

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The paper discussed mechanisms of cordycepin interaction with adenosine receptors and hypothetically linked this to brain protection and COVID-19. Purely theoretical, with no original data.

    DOI 10.26502/jbb.2642-91280035
  • Ko K.M., Leung H.Y., 2007

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The review discussed TCM tonic herbs (Cordyceps as one of several) in the context of ATP, antioxidation and immunomodulation. Does not isolate Cordyceps.

    PMID 17386115
  • Chen S. et al., 2010

    D

    pilot RCT

    20 enrolled, 15 completed

    The pilot randomised study examined the effect of the Cs-4 preparation (a fermented Cordyceps sinensis product) on physical performance in older adults, 20 enrolled, 15 completed.

    PMID 20804368
  • Parcell A.C. et al., 2004

    C

    RCT, double-blind

    22 cyclists

    The double-blind RCT examined the effect of the CordyMax Cs-4 preparation (Cordyceps sinensis) on performance in 22 cyclists.

    PMID 15118196
  • Yu X. et al., 2019

    B

    systematic review with meta-analysis

    14 RCTs, 1192 people

    The systematic review with meta-analysis collected 14 RCTs (1192 people) on Cordyceps sinensis in stable chronic obstructive pulmonary disease (COPD).

    PMID 31073318
  • Wu F. et al., 2025

    B

    systematic review with meta-analysis of RCTs

    15 RCTs, 1310 people

    The meta-analysis collected RCTs on oral Cordyceps sinensis as adjunct therapy in patients with renal dysfunction (creatinine, oliguria duration, urine osmolality). Small samples, short observation periods, predominance of studies from China.

    PMID 39839641
  • Kumar R. et al., 2011

    E

    animal study (rats) · preclinical studies (in vitro and rodent)

    not applicable

    The rat study examined exercise endurance capacity and skeletal muscle metabolic regulators after Cordyceps sinensis administration.

    PMID 21549819
  • Chiou W.F. et al., 2000

    E

    animal (rats) + in vitro (aorta) · preclinical studies (in vitro and rodent)

    not applicable

    The study in anaesthetised rats and isolated aortic rings examined the effect of a Cordyceps sinensis protein fraction on arterial pressure (intravenous administration) and vascular relaxation. Animal model, intravenous administration, does not translate to an oral supplement.

    PMID 10755473

Evidence levels: A · Cochrane review · B · systematic review · C · placebo RCT · D · pilot RCT · E · preclinical studies

What these studies don't say

  • Samples are usually small, most from a single population.
  • Results describe research interventions, not a dietary supplement.
  • The presence of a study is not a health claim.

Source: Aloha Fungi literature review, 1 September 2026; entries verified via PubMed or by DOI (Crossref). See the research

Discover functional mushrooms

© 2026 Aloha Fungi™

🍄 Our mushrooms eat cookies

Essential cookies keep the shop alive (cart, login) · always on. Analytics and marketing cookies help the mycelium grow: they show us what to improve and which stories reach you. We only turn them on with your consent, and you can change it anytime. Cookie policy